| Benefits and risks of antiretroviral therapy for perinatal HIV prevention MG Fowler, M Qin, SA Fiscus, JS Currier, PM Flynn, T Chipato, J McIntyre, ... New England Journal of Medicine 375 (18), 1726-1737, 2016 | 405 | 2016 |
| Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study W Jassat, C Cohen, S Tempia, M Masha, S Goldstein, T Kufa, ... The Lancet HIV 8 (9), e554-e567, 2021 | 181 | 2021 |
| Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study W Jassat, C Mudara, L Ozougwu, S Tempia, L Blumberg, MA Davies, ... The Lancet Global Health 9 (9), e1216-e1225, 2021 | 157 | 2021 |
| Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy K Smith, L Kuhn, A Coovadia, T Meyers, CC Hu, C Reitz, G Barry, ... Aids 23 (9), 1097-1107, 2009 | 114 | 2009 |
| Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy S Arpadi, S Shiau, R Strehlau, L Martens, F Patel, A Coovadia, EJ Abrams, ... Archives of disease in childhood 98 (4), 258-264, 2013 | 74 | 2013 |
| Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children L Kuhn, M Paximadis, B Da Costa Dias, S Loubser, R Strehlau, F Patel, ... PloS one 13 (4), e0195514, 2018 | 73 | 2018 |
| Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency … S Shiau, S Arpadi, R Strehlau, L Martens, F Patel, A Coovadia, EJ Abrams, ... The Journal of pediatrics 162 (6), 1138-1145. e2, 2013 | 72 | 2013 |
| Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis C Reitz, A Coovadia, S Ko, T Meyers, R Strehlau, G Sherman, L Kuhn, ... The Journal of infectious diseases 201 (8), 1121-1131, 2010 | 72 | 2010 |
| Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a … L Kuhn, A Coovadia, R Strehlau, L Martens, CC Hu, T Meyers, G Sherman, ... The Lancet infectious diseases 12 (7), 521-530, 2012 | 65 | 2012 |
| Timing of maternal HIV testing and uptake of prevention of mother-to-child transmission interventions among women and their infected infants in Johannesburg, South Africa KG Technau, E Kalk, A Coovadia, V Black, S Pickerill, CA Mellins, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (5), e170-e178, 2014 | 60 | 2014 |
| Early antiretroviral treatment of infants to attain HIV remission L Kuhn, R Strehlau, S Shiau, F Patel, Y Shen, KG Technau, M Burke, ... EClinicalMedicine 18, 2020 | 54 | 2020 |
| Potential for maternally administered vaccine for infant group B streptococcus SA Madhi, AS Anderson, J Absalon, D Radley, R Simon, B Jongihlati, ... New England Journal of Medicine 389 (3), 215-227, 2023 | 48 | 2023 |
| Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed L Kuhn, DB Schramm, S Shiau, R Strehlau, F Pinillos, K Technau, ... Aids 29 (9), 1053-1060, 2015 | 48 | 2015 |
| Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy R Strehlau, A Coovadia, EJ Abrams, L Martens, S Arpadi, T Meyers, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 60 (4), 369-376, 2012 | 48 | 2012 |
| Efavirenz-based antiretroviral therapy among nevirapine-exposed HIV-infected children in South Africa: a randomized clinical trial A Coovadia, EJ Abrams, R Strehlau, S Shiau, F Pinillos, L Martens, ... Jama 314 (17), 1808-1817, 2015 | 46 | 2015 |
| Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status PM Murnane, SL Sigamoney, F Pinillos, S Shiau, R Strehlau, F Patel, ... AIDS care 29 (3), 378-386, 2017 | 43 | 2017 |
| Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation F Pinillos, C Dandara, M Swart, R Strehlau, L Kuhn, F Patel, A Coovadia, ... BMC infectious diseases 16, 1-7, 2015 | 40 | 2015 |
| Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa BS Taylor, G Hunt, EJ Abrams, A Coovadia, T Meyers, G Sherman, ... AIDS research and human retroviruses 27 (9), 945-956, 2011 | 39 | 2011 |
| Prevalence and outcomes of HIV‐1 diagnostic challenges during universal birth testing–an urban South African observational cohort KG Technau, AH Mazanderani, L Kuhn, L Hans, R Strehlau, EJ Abrams, ... Journal of the International AIDS Society 20, 21761, 2017 | 36 | 2017 |
| Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir-and nevirapine-based treatment S Shiau, L Kuhn, R Strehlau, L Martens, H McIlleron, S Meredith, ... BMC pediatrics 14, 1-10, 2014 | 35 | 2014 |
